Anti-ST6GAL1 Antibody

This polyclonal reagent from Antibodies.com targets ST6GAL1, a Golgi-resident sialyltransferase that catalyzes alpha-2,6-linked sialylation of N-glycoproteins and modulates cell surface biology, immune signaling, and tumor cell adhesion. Raised in rabbit and supplied unconjugated, the antibody is provided as 100 µl of ready-to-use stock and is validated for western blot (WB) and immunofluorescence (IF) workflows on human samples. The polyclonal clonality confers recognition of multiple epitopes across the ST6GAL1 protein, supporting robust detection in whole-cell lysates and fixed-cell preparations. Research applications include profiling sialylation changes linked to epithelial-mesenchymal transition, metastatic behavior, and immune cell interactions, with ST6GAL1 overexpression frequently reported in aggressive breast and ovarian carcinomas. Each vial is quality-controlled for human-specific reactivity with minimal cross-reactivity to closely related sialyltransferases. For best results, store refrigerated, protect from light, and limit freeze-thaw cycles to preserve activity through the stated shelf life.